Related Experiment Video
Updated: Jul 4, 2026

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
Published on: May 10, 2020
Intravenous magnesium for cardiac arrhythmias: jack of all trades
1Department of Intensive Care, Royal Perth Hospital, Perth, Australia. kwok.ho@health.wa.gov.au
Insights
Intravenous magnesium effectively treats various cardiac arrhythmias by influencing the heart's electrical system. However, its efficacy varies, and further research is needed to confirm patient outcome benefits.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Intravenous magnesium is utilized for preventing and treating cardiac arrhythmias.
- Magnesium exerts diverse electrophysiological effects on the heart's conduction system.
Purpose of the Study:
- To review the electrophysiological actions of intravenous magnesium.
- To summarize its reported clinical utility in various cardiac arrhythmias.
- To identify arrhythmias where magnesium is not effective and areas for future research.
Main Methods:
- Literature review of studies on intravenous magnesium and cardiac arrhythmias.
- Analysis of magnesium's electrophysiological effects on cardiac conduction.
- Synthesis of reported clinical outcomes in different arrhythmia types.
Main Results:
- Magnesium prolongs sinus node recovery time and reduces automaticity and conduction.
- It is effective in preventing arrhythmias post-cardiac surgery, managing atrial fibrillation, and treating specific drug-induced arrhythmias.
- Magnesium is not effective for monomorphic ventricular tachycardia and shock-resistant ventricular fibrillation.
Conclusions:
- Intravenous magnesium has a broad range of electrophysiological actions beneficial for certain arrhythmias.
- Its application is established in specific clinical scenarios, but not universally.
- Further large-scale randomized controlled studies are required to confirm its impact on patient-centered outcomes in diverse cardiac arrhythmias.
Abstract:
Intravenous magnesium has been used to prevent and treat many different types of cardiac arrhythmia. It has diverse electrophysiological actions on the conduction system of the heart; including prolonging sinus node recovery time, and reducing automaticity, atrioventricular nodal conduction, antegrade and retrograde conduction over an accessory pathway, and His-ventricular conduction. Intravenous magnesium can also homogenise transmural ventricular repolarisation. Because of its unique and diverse electrophysiological actions, intravenous magnesium has been reported to be useful in preventing atrial fibrillation and ventricular arrhythmias after cardiac and thoracic surgery; in reducing the ventricular response in acute onset atrial fibrillation, including for patients with Wolff-Parkinson-White syndrome; in the treatment of digoxin induced supraventricular and ventricular arrhythmias, multifocal atrial tachycardia, and polymorphic ventricular tachycardia or ventricular fibrillation from drug overdoses. Intravenous magnesium is, however, not useful in monomorphic ventricular tachycardia and shock-resistant ventricular fibrillation. Large randomised controlled studies are needed to confirm whether intravenous magnesium can improve patient centre outcomes in different cardiac arrhythmias.
More Related Videos
09:13Remote Magnetic Navigation for Accurate, Real-time Catheter Positioning and Ablation in Cardiac Electrophysiology Procedures
Published on: April 21, 2013
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Mechanism of Cardiac Arrhythmias